Pymwymic Research
Investment Thesis
Pymwymic describes itself as an investor in transformative technologies with a focus on restoring broken systems. The public site makes the thesis unusually explicit: it wants to back companies that help build a more regenerative food system, support nature, improve fairness for farmers, and create measurable outcomes such as lower chemical inputs, healthier soil, and less food waste. That is a narrower and more operational thesis than a generic “impact” label. The firm is not just telling a sustainability story; it is trying to prove that capital can be used to make food and agriculture more resilient, more traceable, and more beneficial to the people who produce food.
The website and recent announcements reinforce that thesis. Pymwymic positions itself as an “impact guardian” and says it prioritizes practical, tangible impact rather than abstract ESG language. The portfolio page shows the same pattern in practice: the firm backs companies working on traceability, soil health, crop intelligence, biological inputs, food waste reduction, sustainable dairy, and regenerative agriculture. Recent investments in Stenon, Resurrect Bio, Vivent, Doktar, and TRACT all fit that core mandate.
Stage Focus
Pymwymic’s historical material points to a clear early-stage and expansion-stage focus in AgriFood. The homepage states that it invests in Series A to B and ticket sizes up to €5m. Earlier fund materials describe Healthy Food Systems Impact Fund II as focused on early-stage AgriFood scale-ups. The most recent press release shows the platform moving further upmarket as well: the transfer of Triodos Food Transition Europe Fund launched Healthy Food Systems Growth Impact Fund III, which expands the firm into growth-stage investing.
The practical reading is that Pymwymic now spans from early-stage scale-ups through growth, but still within a specialist food and agriculture mandate. It does not read like a broad multi-stage generalist fund. It appears to prefer companies that already have a credible product and a path to scale rather than raw concept-stage ideas.
Check Size
The strongest source-backed number on the public site is a ticket size of up to €5m. I did not find a reliable source for a minimum check size, so I left that unspecified. The firm’s current platform, especially with a new growth fund, suggests flexibility across rounds, but the only figure I would treat as confirmed is the upper bound.
Lead Tendency
Pymwymic appears to be a lead-or-co-lead investor rather than a passive follower. The strongest evidence is direct: it led Stenon’s Series B and co-led Doktar’s >€7m Series B round. That combination suggests the firm is comfortable leading when the deal fits, but it also collaborates with other investors when the round structure or opportunity calls for it. I would characterize the tendency as both.
Recent Activity
Pymwymic has been active across 2025 and 2026. Recent source-backed events include the June 2026 transfer of Triodos Food Transition Europe Fund into Pymwymic’s platform and the launch of Healthy Food Systems Growth Impact Fund III. On the investment side, the firm led Stenon’s Series B on 2026-07-02, invested in Resurrect Bio’s Series A on 2026-02-17, backed Vivent in a €7.5m round announced on 2025-11-20, co-led Doktar’s Series B on 2025-06-24, and announced its investment in TRACT on 2024-12-19.
That sequence matters because it shows continuity rather than drift. The firm is not pivoting away from food and agriculture; it is broadening the capital stack while staying inside the same system-change thesis.
Portfolio Highlights
The portfolio page highlights a dense cluster of food-system and agtech names. Examples visible on the site include TRACT, Stenon, Vivent, Doktar, Resurrect Bio, Rootwave, Seqana, Biome Makers, Ceradis, CrowdFarming, Aurea, and Naturfrisk. The broader portfolio page also shows businesses linked to sustainable farming, supply chain transparency, crop intelligence, and food waste reduction.
There are also clear signs of maturity in the portfolio. The site marks several companies as exited, acquired, or divested, including Augmenta, Ceradis, Naïo, and Yooji. That tells me the firm is not only sourcing new deals but also has enough history to produce realized outcomes.
Team
- Rogier Pieterse, Managing Partner, is the most visible senior leader across the site and appears in the latest fund transfer coverage.
- Pieter Vis, Partner, is listed on the team page and has a LinkedIn presence tied to Pymwymic.
- Monique Meulemans, Partner, is listed on the team page and appears to be part of the core investment group.
- Adam Kybird, Associate Partner, is listed on the team page and is referenced in fund-transfer coverage as a senior dealmaker.
- The team page also lists Josep Segarra Garcia, Marleen Blanson Henkemans, Rik Posthuma, Sophie Pickering, Stella Hak, Stijn Boogaarts, and Yasmine Lurvink.
The team page language emphasizes doing real work on the ground, pushing boundaries, and staying grounded in tangible impact. That is consistent with a specialist fund that does operationally involved investing in a defined sector.
Decision Process
Pymwymic’s decision process appears partnership-oriented and relatively transparent. The site says the process is straightforward and focused on building partnerships that create lasting impact, from start to scale. That suggests founders should expect more than a transactional diligence process: the firm is likely evaluating whether it can be an aligned long-term partner as much as whether the company fits a sector box.
I did not find a reliable public source for an exact decision timeline, warm-intro requirement, or board-seat policy, so I left those unspecified. What is clear is that the firm wants measurable impact and scalable execution, not just thematic alignment.
Founder Preferences
Pymwymic seems to prefer founders who are building practical, measurable solutions to real food-system problems. The site repeatedly addresses “game-changing agri/food startups” and “visionary entrepreneurs” who are rethinking how food is grown, produced, and consumed. The firm also emphasizes scalable, financially sound companies that can deliver positive environmental and social impact.
That combination implies a founder profile with three traits: deep sector insight, operational credibility, and a willingness to work in a long-term partnership. Pymwymic appears to value teams that can translate regenerative intent into a real product, a measurable outcome, and a sustainable business.
Geographic Focus
Pymwymic is Amsterdam-based, with its office on Mauritskade in Amsterdam. The site also says it invests in global companies with a focus on European HQs, and the Triodos transfer coverage notes that the firm now manages a portfolio across 16 countries. So while the firm is rooted in the Netherlands and Europe, its investment lens is broader than a single geography.
The geographic pattern is consistent with the portfolio: European agri-food and climate-adjacent companies, often with international customer bases or cross-border supply chains. The center of gravity is Europe, but the fund’s platform can clearly back companies operating beyond the Netherlands when the food-system thesis fits.